LISBON — The diabetes and weight-loss drug semaglutide improves heart failure–related symptoms and physical limitations regardless of diuretic use in patients with obesity-related heart failure and […]

MILAN — Tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, was more effective than placebo was in the resolution of metabolic […]

An 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded that the investigational anti-amyloid donanemab is effective for the treatment of […]

LISBON — Patients with decompensated heart failure who have bendopnea on discharge from hospital appear to be at significantly increased risk for all-cause mortality within 2 […]

The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of Rheumatology Annual Meeting is about to take place in Vienna, Austria. From June 12-15, […]

Offering colorectal cancer (CRC) screening to patients when they come to the clinic for wellness visits may be the standard of care, but relying on that […]

When doctors and patients consider the appendix, it’s often with urgency. In cases of appendicitis, the clock could be ticking down to a life-threatening burst. Thus, […]

LISBON, Portugal — The addition of a year-long customized yoga therapy intervention to guideline-directed medical therapy (GDMT) appears to significantly improve heart failure measures associated with […]

Hospital-acquired infections associated with antimicrobial resistance (AMR) increased during the COVID-19 pandemic by 32% and remain 13% higher post pandemic compared with prepandemic levels, showed a […]